Laminar Pharmaceuticals
PrivateLast Round
VC Round
Nov 13, 2024
Total Funding Raised
$21.14M
Company Overview
Laminar Pharmaceuticals is a biopharmaceutical company that specializes in the discovery, rational design, and clinical development of drugs based on Membrane Lipid Therapy (MLT) to treat oncological, neurodegenerative, metabolic, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laminar Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Laminar Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 13, 2024 | ||||
| Crowdfunding | Nov 19, 2020 | ||||
| Grant | Dec 1, 2017 |
Key People
Founding team and executive leadership
Laminar Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ok Ventures | Series A |
| Keiretsu Forum | Crowdfunding |
| Grupo Empresas Matutes | VC Round |
| Fundación Alba Pérez | VC Round |
| Fellow Funders | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2024
Raised $9.74M from Grupo Empresas Matutes and Fundación Alba Pérez.
Laminar Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Laminar Pharmaceuticals's valuation, stock price, and market status.